Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.21 -0.48 (-3.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Depreciation & Amortization (CF) (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) reported Depreciation & Amortization (CF) of $600,000 for Q2 2026, down 25.0% from $800,000 a year earlier and down 14.3% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Arcturus Therapeutics Holdings' Depreciation & Amortization (CF) came in at $2.78 million, down 16.2% year-over-year; for FY2025, it came in at $3.03 million, down 14.6% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 27.4% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $3.54 million in FY2024 (+18.1%), $3 million in FY2023 (+96.5%), $1.53 million in FY2022 (+27.3%) and $1.2 million in FY2021 (+33.3%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $224,000 in Q1 2022 and a high of $904,000 in Q1 2024.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last seven quarters, with an average decline of 10.0% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2023 (growth of 167.9%); the low point was Q1 2022 (a decline of 27.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $700,000 (Q1 2026), $682,000 (Q4 2025) and $800,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Arcturus Therapeutics Holdings 389.11 Mn -425.02 Mn - 600,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 600,000.00
Mar 31, 2026 700,000.00
Dec 31, 2025 682,000.00
Sep 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 801,000.00
Dec 31, 2024 819,000.00
Sep 30, 2024 900,000.00
Jun 30, 2024 900,000.00
Mar 31, 2024 904,000.00
Dec 31, 2023 858,000.00
Sep 30, 2023 800,000.00
Jun 30, 2023 700,000.00
Mar 31, 2023 600,000.00
Dec 31, 2022 527,000.00
Sep 30, 2022 400,000.00
Jun 30, 2022 400,000.00
Mar 31, 2022 224,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 300,000.00
API Access

Arcturus Therapeutics Holdings Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ARCT&period=max&api_key=YOUR_API_KEY